Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)
Apply
mBTCvax, Durvalumab, Tremelimumab
Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step